Low/Intermediate PCa Video Chat, February 9, 2026

Low/Intermediate PCa Video Chat, February 9, 2026

by | Feb 10, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, February 9, 2026

Low/Intermediate PCa Video Chat, February 9, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Feeling comfortable with your medical team today avoids treatment regret in the future. (bj)

Topics Discussed
Importance of getting a second reading/opinion on your prostate cancer biopsy results; go to a center of excellence for your treatment; concerns about the validity of the PROSTOX genetic test; concerns that some medical teams recommendations are out-dated and/or not aligned with current best practices for standards of care; feeling comfortable with your medical team today avoids treatment regret in the future; understanding medicare costs for consultations and procedures, your out-of-pocket costs may not be as bad you think; rising PSA after treatment when should you worry; considering treatment options surgery, radiation, and ADT.

Chat

Stuart sent a chat · 7:50 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Stuart sent a chat · 7:51 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan – Rick sent a chat · 8:12 PM
Dr. Ming Zhou   https://profiles.mountsinai.org/ming-… Ming.zhou@mountsinai.org  212 241-8881

AnCan – Rick sent a chat · 8:14 PM
Dr. Jonathan Epstein   Ep-stine! Dr. Jonathan Epstein – https://advanceduropathology.com/ Tel: 516-760-2037 jepstein@imppllc.com

“Playing the Long Game” – Does your Recurrent/Advanced Prostate Cancer Need Treating? NCI Seminar

“Playing the Long Game” – Does your Recurrent/Advanced Prostate Cancer Need Treating? NCI Seminar

by | Jan 30, 2026 | High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, mCRPC, mHSPC, nmCRPC, Recent News, Recorded Groups, Uncategorized, Webinars

“Playing the Long Game” – Does your Recurrent/Advanced Prostate Cancer Need Treating?

National Cancer Institute Seminar with Dr. Ravi Madan and Dr. Melissa Abel,  Jan 30, 2026

READ THROUGH – you won’t regret it!! (rd)

A recent article in the Journal of Clinical Oncology with a very dry title caught our eye – National Cancer Institute’s Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations

AnCan has long been perplexed by the prostate cancer category “non-metastatic Castrate Resistant” or even “non-metastatic Hormone Sensitive”. If PSA is rising after primary treatment but prior to hormone treatment, something’s going on, however, ‘micro-metastatic’. It’s like being just a little bit pregnant!!

This paper considers a new category, PSMA Positive Biochemically Recurrent – PSMA+ BCR. We circulated the paper to our Brains Trust and reached out to Dr. Ravi Madan at the National Cancer Institute (NCI) with a couple of questions. Dr Madan offered to meet with us along with his colleague, Dr. Melissa Abel. What resulted was this REMARKABLE video that could present many of our recurrent and advanced AnCan (& non-AnCan) participants with one of the most mind-blowing videos many have seen in a long time,

DO YOU REALLY NEED TREATMENT??

As the venerable and highly respected Dr. Paul Schellhammer said in the meeting, “it’s like listening 15 years ago to the folks who began to promote active surveillance ( in first line treatment)”     Dr. Madan and Dr. Abel have collected solid data from around 150 patients that suggests men with slow PSA doubling times can “play the long game” as Dr. Ravi calls it, and defer active treatment when their disease recurs.

PLEASE watch this astonishing presentation, listen to some excellent observations and questions, and consider how it relates to your own situation. And spread the word to others. Dr. Madan’s and Dr. Abel’s NCI clinical trial can be found at https://www.clinicaltrials.gov/study/NCT05588128. Don’t immediately assume you’re not eligible before speaking with them… but you’ll have to watch the video to get their contact information.

Low/Intermediate PCa Video Chat, February 9, 2026

Low/Intermediate PCa Video Chat, January 26, 2026

by | Jan 28, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, January 26, 2026

Low/Intermediate PCa Video Chat, January 26, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Dangers of high PSA going untreated. (bj)

Topics Discussed
Dangers of high PSA going untreated; strategies for getting past treatment decision anxiety and worries about side effects; getting a second opinion with VA Healthcare and accessing community care; aquablation therapy and steady PSA; cribriform concerns; health care team more important than the technology; focal therapy—understanding if you are a good candidate; research is good, but you can overdo it; using MSKCC nomogram to determine how likely you will need treatment after surgery; advantages of MR-Linac for radiation treatment; incorporating multiple comorbidities into your treatment decision; concerns with MR-Linac with urinary flow issues; Heatwave study; Androgen Deprivation Therapy (ADT) therapy discussion to include monotherapy and LRHR (luteinizing hormone-releasing hormone receptor); benefits of participating in trials.

Chat

AnCan – Stuart sent a chat · 8:00 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 8:00 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Larry S – Alaska-Veteran-ADT by estradiol sent a chat · 8:40 PM
Exercise begets energy

Bill Franklin sent a chat · 8:41 PM
Stuart did it!

Larry S – Alaska-Veteran-ADT by estradiol sent a chat · 8:42 PM
Exercise also affects the chemistry n your body and has a small but real anti-cancer effect.  Plus a healthy, well exercised body is better able to withstand the rigors of treatment.

Henry sent a chat · 8:59 PM
Community care ask your primary doc to refer you

AnCan – Boykin sent a chat · 9:01 PM
AnCan Veterans Healthcare Navigation Feb 3, 2026

Veterans Healthcare Navigation

Henry sent a chat · 9:02 PM
Personally I would get away from the VA and get an outside Doctor.

Paul N. sent a chat · 9:05 PM
Sorry. Is the start time for tomorrow’s Advanced Meeting 6:00 or 6:30?

Bill Franklin sent a chat · 9:05 PM
6 p.m. Eastern Paul

Paul N. sent a chat · 9:05 PM
Thank you.

Bill Franklin sent a chat · 9:07 PM
All of the information about AnCan groups is on our Event Calendar:  https://ancan.org/events/month/

Paul N. sent a chat · 9:07 PM
Thx.

Paul N. sent a chat · 9:08 PM
I will exit this meeting now. Good night.

Bill Franklin sent a chat · 9:08 PM
Take care Paul

Larry S – Alaska-Veteran-ADT by estradiol sent a chat · 9:11 PM
Dr Robert Bruce Mongomery or Dr M. Schweizer

AnCan – Rick sent a chat · 9:13 PM
Not Schweizer – he’s a medical oncologist

AnCan – Rick sent a chat · 9:15 PM
Dr. Daniel Lin is another alternative urological oncologist at Hutch

AnCan – Rick sent a chat · 9:21 PM
MSKCC nomogram  http://nomograms.mskcc.org/Prostate/index.aspx

Larry S – Alaska-Veteran-ADT by estradiol sent a chat · 9:22 PM
to learn more about estradiol-based ADT, see the web site “estradiolinitiative.org”

AnCan – Rick sent a chat · 9:34 PM
PROTECT study re. cribriform favors RT
https://jamanetwork.com/journals/jamaoncology/fullarticle/2840006

AnCan – Rick sent a chat · 9:37 PM
“patients with cribriform-negative prostate cancer are at low risk of long-term metastasis regardless of baseline treatment, whereas patients with cribriform-positive prostate cancer are at high risk of metastasis that is potentially reduced in those receiving radiotherapy with neoadjuvant ADT.”

AnCan – Rick sent a chat · 9:52 PM
HEATWAVE  trial https://www.clinicaltrials.gov/study/NCT06067269

Shirrell Roberts sent a chat · 10:01 PM
Have to drop. Y’all have a good evening!

Bill Franklin sent a chat · 10:03 PM
A cardio-oncologist, is a heart specialist who manages cardiovascular health for cancer patients, focusing on preventing and treating heart problems (cardiotoxicity) caused by cancer treatments like chemotherapy or radiation.

AnCan – Boykin sent a chat · 10:06 PM
LHRH – Luteinizing Hormone-Releasing Hormone

AnCan – Rick sent a chat · 10:24 PM
Dr. Javid Moslehi  UCSF  https://profiles.ucsf.edu/javid.moslehi

Low/Intermediate PCa Video Chat, February 9, 2026

Low/Intermediate PCa Video Chat, January 12, 2026

by | Jan 14, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, January 12, 2026

Low/Intermediate PCa Video Chat, January 12, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Using DECIPHER genomic testing to assess cancer agressiveness. (bj)

Topics Discussed
Cancer discovery following an aquablation procedure for an enlarged prostate; post-procedure PSA and MRI testing to monitor remaining cancer; comparing transrectal and transperineal biopsy safety and access; importance of consulting genitourinary oncologists at major centers; using specialists like Dr. Epstein for pathology second opinions; weighing active surveillance against the risk of cancer progression; discussion of MR LINAC, proton, and photon radiation technologies; using PSMA PET scans to detect potential lymph node involvement; selecting high-volume urban medical centers over smaller clinics; using DECIPHER genomic testing to assess cancer agressiveness.

Chat

Stuart sent a chat · 8:01 PM
Dr. Ming Zhou – Mt Sinai Health System  Email: Ming.zhou@mountsinai.org      Telephone: (212)241-8881

Stuart sent a chat · 8:02 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Steve in Malaysia sent a chat · 8:39 PM
What is an AI MRI?

Steve in Malaysia sent a chat · 8:42 PM
ok 👍

AnCan – rick sent a chat · 8:48 PM
Proton vs Photon  https://ascopubs.org/doi/abs/10.1200/JCO.23.01604?md5=efb3c3159aa147415d4f2ded3334efa3&cid=DM16707&bid=358786211

Gil Solomon sent a chat · 8:52 PM
Have to sign off for dinner.

Steve in Malaysia sent a chat · 8:57 PM
I need to finish packing for trip from Penang to California shortly so would appreciate some quick questions.

AnCan – rick sent a chat · 9:07 PM
Check our AnCan video with Dr. Scholz  on Prostate Snatchers. https://ancan.org/the-prostate-snatchers-still-lurking/

Steve sent a chat · 9:14 PM
Carter

AnCan – rick sent a chat · 9:25 PM
Steve – CHEK2 may in fact make you more sensitive to RT. Check with Dr. Kivel

Steve sent a chat · 9:28 PM
Thanks Rick!

David in Portland, OR sent a chat · 9:39 PM
“Most mutations in DNA repair genes such as BRCA1/2, PALB2, CHEK2, and RAD50/51 mutations do not increase radiation-induced cancers or radiation toxicity. BRCA1/2, PALB2, CHEK2, and RAD50/51 mutations should not affect radiation therapy decisions.” Source: https://www.redjournal.org/article/S0360-3016(19)33530-8/fulltext I also communicated with Joanne Wiedhaas last year directly about this topic, and she confirmed the above quote from the International Journal of Radiation Oncology.

Govinda – India sent a chat · 9:41 PM
Daily dosage of  Viagra was 5 mg daily. Of course this varies from person to person.

Steve in Malaysia sent a chat · 9:42 PM
I’m going to sign off… thanks guys

David in Portland, OR sent a chat · 9:42 PM
5 milligrams/day of tadalafil/Cialis gives me significant heartburn. Anybody else have this problem? Any fixes other than stopping the Cialis?

AnCan – rick sent a chat · 9:51 PM
Interesting David….    the general opinion is that HRR mutations make you more sensitive to RT toxicity. I think there’s a fair amount of literature.

Stuart sent a chat · 9:56 PM
Dr James Hu – Weill Cornell

Stuart sent a chat · 9:56 PM
Dr Nagar – MSKCC

Stuart sent a chat · 9:57 PM
or Michael J. Zelefsky, MD – NYU Langone

Steve sent a chat · 10:17 PM
Thanks David!

Low/Intermediate PCa Video Chat, December 22, 2025

Low/Intermediate PCa Video Chat, December 22, 2025

by | Jan 7, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, December 22, 2025

Low/Intermediate PCa Video Chat, December 22, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Importance of getting your treatment at a NCCN Member Institution. (bj)

Topics Discussed
New quarterly support group for inherited mutations (e.g., BRCA, Lynch syndrome); eligibility for active surveillance despite a high-intermediate decipher score (0.57) and specific biopsy results (Gleason 3+4 with 10% grade 4); importance of obtaining a second opinion on biospy slides; importance of getting your treatment at a National Comprehensive Cancer Network (NCCN) Member Institution versus other medical institutions; nutrional and lifestyle approaches (e.g., fasting, ketogenic diets) before radiation; MRI-guided radiation (SBRT) and the experience of having fiducials and barriers implanted under local anesthesia; management of side effects like erectile dysfunction (ED) and the benefits of heavy exercise during long-term treatment; challenges faced by patients living abroad; concerns about inguinal hernia mesh repair complicating a future prostatectomy; lack of definitive ways to prevent prostate cancer; various theories regarding calcium levels.

Chat

AnCan – Stuart sent a chat · 8:02 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 8:03 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan – rick sent a chat · 8:12 PM
877 582 7011

AnCan – rick sent a chat · 8:13 PM
GoTo Technical Help

David K – Jacksonville FL sent a chat · 8:18 PM
aquablation and PAE: I’ll be asking if anyone has had an aquablation or a Prostate Artery Embolization. – david K

AnCan – rick sent a chat · 8:38 PM
We are looking at a spckof cancer here…. half a millimeter

AnCan – rick sent a chat · 8:39 PM
*speck of

Steve in Malaysia sent a chat · 8:41 PM
Does anyone have contact info for support staff of Dr Epstein as I’ve been trying to get slides to Stanford

Steve in Malaysia sent a chat · 8:41 PM
He has them now

Steve in Malaysia sent a chat · 8:43 PM
I did email him a few days ago but no answer

Frank H sent a chat · 8:43 PM
Try ask for Mary jones

Steve in Malaysia sent a chat · 8:44 PM
Thanks Frank, do you have her email?

AnCan Bill sent a chat · 8:44 PM
Steve, you can check his website: https://advanceduropathology.com/

AnCan Bill sent a chat · 8:44 PM
Frank did say he was on vacation for the holidays.

Steve in Malaysia sent a chat · 8:45 PM
My issue is more that I need to get my slides from him to Stanford soon as I’m going to US mid Jan

Frank H sent a chat · 8:47 PM
I will need to check with her myself tomorrow

Greg sent a chat · 9:04 PM
When does Medicare stop paying for Telehealth?

AnCan – rick sent a chat · 9:05 PM
Right around now, we beleive.

Greg sent a chat · 9:06 PM
For just prostate consults or across the board visits?

AnCan – rick sent a chat · 9:06 PM
Check on the internet, Greg

AnCan – rick sent a chat · 9:06 PM
Across tehe board.

AnCan – rick sent a chat · 9:16 PM
Cancer & Fasting UCSF  https://osher.ucsf.edu/patient-care/integrative-medicine-resources/cancer-and-nutrition/faq/cancer-and-fasting-calorie-restriction

AnCan – rick sent a chat · 9:17 PM
QiL fasting during chemo https://www.vumedi.com/video/esmo-2023-insights-effects-of-short-term-fasting-on-quality-of-life-as-an-add-on-option-during-chemo/?token=aea546f6-9f4e-41f5-98fd-3a2f2c6f6add&link_data=eyJiZXRfbWFpbF9pdGVtX2lkIjoyMDAwODM0MjQsImJldF9tYWlsX2FjdGlvbiI6ImJjIn0%3A1ryYHH%3A2ho3Ayar__FqeFstiJEPOgl60cTKcylOggsW5v-BNKQ&mc_cid=af2eade45f&mc_eid=838454d636

AnCan – rick sent a chat · 9:18 PM
Meta study from Kishan on ADT duration https://jamanetwork.com/journals/jamaoncology/article-abstract/2841671?guestAccessKey=d03b0908-90c8-497e-85cd-aebb43ec2a63&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jamaoncology&utm_content=olf-tfl_&utm_term=112025&mc_cid=0fa42784f6&mc_eid=838454d636

AnCan – rick sent a chat · 9:19 PM
Gil – also Spratt is on the metastudy.

Greg sent a chat · 9:20 PM
Which guys at Stanford?

Gil Solomon sent a chat · 9:34 PM
Thanks. I did see the ADT duration study and diminishing returns after 6 months

Gil Solomon sent a chat · 9:36 PM
Apalutamide study HEATWAVE and it is all comers regardless of cell type.

Gil Solomon sent a chat · 9:37 PM
I’m going to sign off for dinner.  Thanks all.

AnCan Bill sent a chat · 9:37 PM
Have a good night Gil

Steve in Malaysia sent a chat · 9:40 PM
Thanks for info Gil

AnCan – rick sent a chat · 9:43 PM
But we know that f you are Lumin A, apalutamide does not work.  Balance trial  https://ascopost.com/issues/october-25-2025/biomarker-driven-apalutamide-therapy-for-patients-with-recurrent-prostate-cancer/?mc_cid=17ff95d283&mc_eid=838454d636

Steve in Malaysia sent a chat · 9:47 PM
How long after last PSA read (was same time as MRI) should I get next one?

Steve in Malaysia sent a chat · 9:47 PM
That as Oct 12

Steve in Malaysia sent a chat · 9:47 PM
*was

AnCan Bill sent a chat · 9:50 PM
Steve, you’re 2 and a half months out from the last one but you don’t  have an urgent need to get PSA right now unless your doctor thinks you should.

Greg sent a chat · 9:51 PM
Will there be another email for donation?

AnCan – rick sent a chat · 9:51 PM
bfranklin@ancan.org

AnCan – rick sent a chat · 9:52 PM

Donate

Steve in Malaysia sent a chat · 9:52 PM
Thanks Bill, I’m a bit concerned as it went from 2.22 to 4.33 in 3 weeks

Steve in Malaysia sent a chat · 9:54 PM
I’ll ask Dr Sonn if needed before consult.

AnCan Bill sent a chat · 9:54 PM
When I was in your situation, I was getting it every 3 months at my doctor’s advice.

AnCan Bill sent a chat · 9:55 PM
Talk to your doc but remember, it can lead to increase anxiety.

Steve in Malaysia sent a chat · 9:55 PM
I understand re: anxiety

Steve in Malaysia sent a chat · 9:55 PM
I had an infection and was on cipro (but finished) right before last read.

AnCan Bill sent a chat · 9:58 PM
Ah, the infection could definitely be a contributer.

Steve in Malaysia sent a chat · 9:58 PM
oddly that infection was what lead to actual detection of cancer.

AnCan – rick sent a chat · 10:02 PM
Steve – the 4.33 could have a huge amount to do with the infection. I’d repeat the PSA sooner rather than later.

Steve in Malaysia sent a chat · 10:03 PM
ok, will do before I go to CA

AnCan – rick sent a chat · 10:04 PM
If it’s 2.33 what would you do, Steve?

Steve in Malaysia sent a chat · 10:05 PM
Hmmm…. not sure … I would still proceed with process I think given Epstein and Klotz recommendations.

AnCan – rick sent a chat · 10:06 PM
Stay in the moment!!!!

Steve in Malaysia sent a chat · 10:14 PM
Good luck with treatment Greg

Is It OK to Take Supplements After a Prostate Cancer Diagnosis?

Is It OK to Take Supplements After a Prostate Cancer Diagnosis?

by | Dec 28, 2025 | Cancer Resources, Health Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, mHSPC, Nutrition, Prostate Cancer, Recent News

Is It OK to Take Supplements After a Prostate Cancer Diagnosis?  by Stuart Jordan

We were recently asked by a newly diagnosed member of our group—who is preparing to begin treatment—about a dietary supplement he has been taking. His question had two parts: Could this supplement help with prostate cancer? And just as important, is it safe to keep taking it now?

It’s a fair question, and a very common one. Many supplements are marketed as supportive of prostate health, metabolism, or weight management, and it’s easy to assume they might be helpful during cancer treatment.

In my day job as publisher of the Wellness Letter, we often see how supplement claims outpace the science behind them. That’s why we rely on evidence-based research as the final word when exploring questions like these.

When we look closely at the research, the picture is clearer than the marketing suggests. So far, no dietary supplement has been shown in solid human studies to prevent, treat, or slow the progression of prostate cancer once diagnosed. Some supplements that once sounded promising haven’t held up in careful trials. Others affect lab markers, such as PSA, without improving outcomes that truly matter. In fact, some supplements—like high-dose vitamin E or selenium—have actually shown potential harm in trials.

Safety is just as important. Supplements and over-the-counter products can interact with medications, affect lab results, or interfere with how treatments work. This matters whether a man is on active surveillance, receiving hormone therapy, undergoing radiation therapy, or after treatment. Even products that seem harmless can complicate care if the medical team isn’t aware of them.

That’s why it’s essential to tell your doctors about every supplement and over-the-counter product you’re taking, not just prescriptions.

Instead of relying on supplements, focusing on overall health—through diet, physical activity, weight management, and addressing true deficiencies—offers a safer, better-supported path, especially when coordinated closely with your medical team.

-Stuart Jordan